Celldex Therapeutics buy Morgan Stanley
Start price
20.03.25
/
50%
€18.40
Target price
20.03.26
€42.18
Performance (%)
42.39%
End price
21.03.26
€26.20
Summary
This prediction ended on 21.03.26 with a price of €26.20. With a performance of 42.39% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 7.399% | 7.399% | 63.119% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $46.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€30.47
22.07.26
22.07.26
€35.07
22.07.27
22.07.27
9.48%
31.07.26
31.07.26
Stopped prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€16.30
09.05.25
09.05.25
€38.34
09.05.26
09.05.26
74.29%
10.05.26
10.05.26